Annual Operating Profit
-$67.98 M
+$23.16 M+25.42%
December 31, 2023
Summary
- As of February 20, 2025, CSTL annual operating income is -$67.98 million, with the most recent change of +$23.16 million (+25.42%) on December 31, 2023.
- During the last 3 years, CSTL annual operating profit has fallen by -$61.44 million (-939.09%).
- CSTL annual operating profit is now -1027.63% below its all-time high of $7.33 million, reached on December 31, 2019.
Performance
CSTL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$5.08 M
+$67.00 K+1.34%
September 30, 2024
Summary
- As of February 20, 2025, CSTL quarterly operating income is $5.08 million, with the most recent change of +$67.00 thousand (+1.34%) on September 30, 2024.
- Over the past year, CSTL quarterly operating profit has increased by +$10.74 million (+189.77%).
- CSTL quarterly operating profit is now at all-time high.
Performance
CSTL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$1.04 M
+$14.72 M+93.41%
September 30, 2024
Summary
- As of February 20, 2025, CSTL TTM operating income is -$1.04 million, with the most recent change of +$14.72 million (+93.41%) on September 30, 2024.
- Over the past year, CSTL TTM operating profit has increased by +$66.94 million (+98.47%).
- CSTL TTM operating profit is now -110.95% below its all-time high of $9.48 million, reached on September 30, 2019.
Performance
CSTL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CSTL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.4% | +189.8% | +98.5% |
| 3 y3 years | -939.1% | +189.8% | +98.5% |
| 5 y5 years | -1672.1% | +189.8% | +98.5% |
CSTL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.6% | +25.4% | at high | +116.1% | at high | +99.0% |
| 5 y | 5-year | -1027.6% | +25.4% | at high | +116.1% | -112.0% | +99.0% |
| alltime | all time | -1027.6% | +25.4% | at high | +116.1% | -111.0% | +99.0% |
Castle Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.08 M(+1.3%) | -$1.04 M(-93.4%) |
| Jun 2024 | - | $5.01 M(-191.6%) | -$15.76 M(-62.4%) |
| Mar 2024 | - | -$5.47 M(-3.3%) | -$41.93 M(-38.3%) |
| Dec 2023 | -$67.98 M(-25.4%) | -$5.66 M(-41.3%) | -$67.98 M(-20.4%) |
| Sep 2023 | - | -$9.64 M(-54.4%) | -$85.45 M(-12.4%) |
| Jun 2023 | - | -$21.16 M(-32.9%) | -$97.50 M(-3.2%) |
| Mar 2023 | - | -$31.52 M(+36.3%) | -$100.71 M(+10.5%) |
| Dec 2022 | -$91.14 M(+127.4%) | -$23.13 M(+6.7%) | -$91.14 M(+9.6%) |
| Sep 2022 | - | -$21.69 M(-11.0%) | -$83.18 M(+13.5%) |
| Jun 2022 | - | -$24.37 M(+11.0%) | -$73.31 M(+26.9%) |
| Mar 2022 | - | -$21.95 M(+44.7%) | -$57.75 M(+44.1%) |
| Dec 2021 | -$40.08 M | -$15.17 M(+28.4%) | -$40.08 M(+43.4%) |
| Sep 2021 | - | -$11.81 M(+34.1%) | -$27.94 M(+39.5%) |
| Jun 2021 | - | -$8.81 M(+105.6%) | -$20.03 M(+68.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$4.28 M(+41.3%) | -$11.86 M(+81.3%) |
| Dec 2020 | -$6.54 M(-189.3%) | -$3.03 M(-22.3%) | -$6.54 M(+629.3%) |
| Sep 2020 | - | -$3.90 M(+504.8%) | -$897.00 K(-112.1%) |
| Jun 2020 | - | -$645.00 K(-162.3%) | $7.43 M(-14.4%) |
| Mar 2020 | - | $1.04 M(-60.4%) | $8.69 M(+18.5%) |
| Dec 2019 | $7.33 M(-291.0%) | $2.61 M(-41.0%) | $7.33 M(-22.7%) |
| Sep 2019 | - | $4.43 M(+628.5%) | $9.48 M(+330.7%) |
| Jun 2019 | - | $608.00 K(-288.8%) | $2.20 M(-305.1%) |
| Mar 2019 | - | -$322.00 K(-106.8%) | -$1.07 M(-72.0%) |
| Dec 2018 | -$3.84 M(-64.8%) | $4.77 M(-267.2%) | -$3.84 M(-55.4%) |
| Sep 2018 | - | -$2.85 M(+6.9%) | -$8.60 M(+49.6%) |
| Jun 2018 | - | -$2.67 M(-13.6%) | -$5.75 M(+86.4%) |
| Mar 2018 | - | -$3.08 M | -$3.08 M |
| Dec 2017 | -$10.90 M | - | - |
FAQ
- What is Castle Biosciences annual operating income?
- What is the all time high annual operating profit for Castle Biosciences?
- What is Castle Biosciences annual operating profit year-on-year change?
- What is Castle Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Castle Biosciences?
- What is Castle Biosciences quarterly operating profit year-on-year change?
- What is Castle Biosciences TTM operating income?
- What is the all time high TTM operating profit for Castle Biosciences?
- What is Castle Biosciences TTM operating profit year-on-year change?
What is Castle Biosciences annual operating income?
The current annual operating profit of CSTL is -$67.98 M
What is the all time high annual operating profit for Castle Biosciences?
Castle Biosciences all-time high annual operating income is $7.33 M
What is Castle Biosciences annual operating profit year-on-year change?
Over the past year, CSTL annual operating income has changed by +$23.16 M (+25.42%)
What is Castle Biosciences quarterly operating income?
The current quarterly operating profit of CSTL is $5.08 M
What is the all time high quarterly operating profit for Castle Biosciences?
Castle Biosciences all-time high quarterly operating income is $5.08 M
What is Castle Biosciences quarterly operating profit year-on-year change?
Over the past year, CSTL quarterly operating income has changed by +$10.74 M (+189.77%)
What is Castle Biosciences TTM operating income?
The current TTM operating profit of CSTL is -$1.04 M
What is the all time high TTM operating profit for Castle Biosciences?
Castle Biosciences all-time high TTM operating income is $9.48 M
What is Castle Biosciences TTM operating profit year-on-year change?
Over the past year, CSTL TTM operating income has changed by +$66.94 M (+98.47%)